General Category > NF2

NF2 clinical trial at MGH

(1/1)

Susan A:
Dr Plotkin at Mass General Hospital is starting a new Phase 2 clinical trial for people with NF2. The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.

mwatto:
https://www.nature.com/articles/s41598-020-60156-6

Navigation

[0] Message Index